Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

Chardan Capital analyst Andreas Argyrides has initiated coverage on MannKind (NASDAQ: MNKD) with a Buy rating. The firm has set a price target of $10 for the company's stock.